Should lymphadenectomy be recommended in radical surgery of intrahepatic cholangiocarcinoma patients? A retrospective study
Open Access
- 12 March 2025
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 151 (3) , 1-22
Abstract
Purpose Intrahepatic cholangiocarcinoma (ICC) is an extremely deadly cancer with high recurrence incidence, particularly in patients with lymph node metastasis (LNM). The necessity of lymphadenectomy including lymph node biology (LNB) and dissection (LND) during ICC radical surgery remains debate. Methods We retrospectively analyzed the patients diagnosed with ICC and underwent radical surgery at the Cancer Hospital of the Chinese Academy of Medical Sciences from 2012 to 2023. Results A total of 308 ICC patients were involved in this study. pLNM+ group had poorer OS (P < 0.0001) and poorer DFS (P < 0.0001) compared with pLNM− group. Compared to the LN− group, LN+ group exhibited worse OS (P = 0.038) and worse DFS (P = 0.003). After PSM and IPTW, compared with LN− group, LNB exhibited longer operation time (IPTW: P = 0.0024) and longer hospitalization days (IPTW: P = 0.0112) with no significant differences in complications, DFS, and OS. Compared with LN− group, LND group had no better DFS and OS, only more complications (IPTW: P = 0.0191), longer operation time (all P < 0.001), higher risk of bleeding (all P < 0.05), transfusion (IPTW: P = 0.014) and longer hospitalization days (IPTW: P = 0.0044). Compared with LNB group, LND had longer operation time (P = 0.0227), higher risk of bleeding (P = 0.017) and transfusion (P = 0.0321), and more postoperative complications (P = 0.0425), with no difference in DFS and OS. Conclusion Lymphadenectomy does not necessarily provide long-term survival or recurrence benefits. LND only achieves the effect of LNB while negatively affects postoperative recovery without survival benefit for ICC patients. LNB can be performed for accurate pathological staging while not all patients may require LND based on their specific circumstances.Keywords
All Related Versions
Funding Information
- CAMS Innovation Fund for Medical Sciences (2022-I2M-C&T-B-062)
This publication has 53 references indexed in Scilit:
- Body composition is associated with disease aetiology and prognosis in patients undergoing resection of intrahepatic cholangiocarcinomaCancer Medicine, 2023
- Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population‐based studyCancer Medicine, 2023
- Long‐term outcomes of laparoscopic versus open liver resection for intrahepatic combined hepatocellular‐cholangiocarcinoma with propensity score matchingAnnals of Gastroenterological Surgery, 2022
- Sentinel lymph node detection by combining nonradioactive techniques with contrast agents: State of the art and prospectsJournal of Biophotonics, 2021
- Preoperative criterion identifying a low‐risk group for lymph node metastasis in intrahepatic cholangiocarcinomaJournal of Hepato-Biliary-Pancreatic Sciences, 2018
- Trends in use of lymphadenectomy in surgery with curative intent for intrahepatic cholangiocarcinomaBritish Journal of Surgery, 2018
- Surgical Management of Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Impact of Lymphadenectomy on Peri‐Operative OutcomesWorld Journal of Surgery, 2018
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studiesStatistics in Medicine, 2015
- The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphaticsJournal of Gastroenterology, 2015
- A Nomogram to Predict Long-term Survival After Resection for Intrahepatic CholangiocarcinomaJAMA Surgery, 2014